PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications

The new immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human cancers to treat. Among these, there are the poorly differentiated and anaplastic thyroid cancers, unresponsive to all the therapies curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulisse, Salvatore, Tuccilli, Chiara, Sorrenti, Salvatore, Antonelli, Alessandro, Fallahi, Poupak, D’Armiento, Eleonora, Catania, Antonio, Tartaglia, Francesco, Amabile, Maria Ida, Giacomelli, Laura, Metere, Alessio, Cornacchini, Nicola, Pironi, Daniele, Carbotta, Giovanni, Vergine, Massimo, Monti, Massimo, Baldini, Enke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471477/
https://www.ncbi.nlm.nih.gov/pubmed/30897754
http://dx.doi.org/10.3390/ijms20061405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471477/
https://www.ncbi.nlm.nih.gov/pubmed/30897754
http://dx.doi.org/10.3390/ijms20061405

Ejemplares similares